Stock RLF RELIEF THERAPEUTICS HOLDING SA
Add to a list
To use this feature you must be a member
Log inSign up

All News Relief Therapeutics Holding SA

Equities

RLF

CH1251125998

End-of-day quote Swiss Exchange
Other stock markets
 23:00:00 24/04/2024 BST 		5-day change 1st Jan Change
1.25 CHF -6.72% Intraday chart for Relief Therapeutics Holding SA -4.58% -37.19%
03-22 Sector Update: Health Care Stocks Steady Pre-Bell Friday MT
03-22 Sector Update: Health Care MT

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
RELIEF THERAPEUTICS Holding SA to Hold Extraordinary General Meeting
AQ
Sector Update: Health Care Stocks Steady Pre-Bell Friday
MT
Sector Update: Health Care
MT
Eton Pharmaceuticals Acquires US Rights to Phenylketonuria Dietary Management Product
MT
Relief Therapeutics Grants Eton Pharmaceuticals Exclusive License for US Commercialization of Golike
MT
Relief Therapeutics Enters into Exclusive U.S. License and Supply Agreement with Eton Pharmaceuticals for PKU GOLIKE
CI
Eton Pharmaceuticals Announces Acquisition of PKU GOLIKE® for Phenylketonuria
AQ
Relief Therapeutics Extends CHF50 Million Share Subscription Facility with Largest Shareholder
MT
Relief Therapeutics Holding SA announced that it expects to receive CHF 50 million in funding from Global Emerging Markets and another investor
CI
Relief Therapeutics Shifts Commercial Operations to Partnership Model, Focusing on Efficient Patient Access and R&D Growth
AQ
Relief Therapeutics to Run Commercial Operations Via Partnership Model
MT
Relief Therapeutics Announces CEO Transition
AQ
Relief Therapeutics CEO to Leave; Interim Successor Takes Over
MT
Relief Therapeutics Holding Sa Announces CEO Changes
CI
Relief Therapeutics announces that more than 400,000 of its ADRs are currently outstanding and that, as a result, the Company has achieved an Important NASDAQ Initial Listing Milestone
AQ
Relief Therapeutics Meets Outstanding ADR Requirement for Nasdaq Listing
MT
Relief Therapeutics Reports Half-Year 2023 Financial Results and Provides Corporate Update
AQ
Relief Therapeutics Holding AG(SWX:RLF) dropped from S&P Global BMI Index
CI
Relief Therapeutics Holding AG Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Relief Therapeutics Posts Wider H1 Loss; Revenue Down
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. RLF Stock
  4. News Relief Therapeutics Holding SA